Apollo Endosurgery Inc organizacji Net debt/EBITDA
Jaka jest wartość Net debt/EBITDA organizacji Apollo Endosurgery Inc?
Wartość Net debt/EBITDA organizacji Apollo Endosurgery Inc to -4.26
Jaka jest definicja Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA firm w Health Care sektor na NASDAQ w porównaniu do Apollo Endosurgery Inc
Czym się zajmuję organizacja Apollo Endosurgery Inc?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Firmy z net debt/ebitda podobne do Apollo Endosurgery Inc
- Wartość Net debt/EBITDA organizacji Tremor International Ltd to -4.27
- Wartość Net debt/EBITDA organizacji Bigben Interactive SA to -4.27
- Wartość Net debt/EBITDA organizacji BigBen Interactive to -4.27
- Wartość Net debt/EBITDA organizacji Touchwood Entertainment to -4.27
- Wartość Net debt/EBITDA organizacji Quotient Technology Inc to -4.26
- Wartość Net debt/EBITDA organizacji GR Engineering Services to -4.26
- Wartość Net debt/EBITDA organizacji Apollo Endosurgery Inc to -4.26
- Wartość Net debt/EBITDA organizacji Sto SE & Co. KGaA to -4.25
- Wartość Net debt/EBITDA organizacji Sto SE & Co. KGaA to -4.25
- Wartość Net debt/EBITDA organizacji Cyprium Metals to -4.25
- Wartość Net debt/EBITDA organizacji NextStage - S.C.A to -4.24
- Wartość Net debt/EBITDA organizacji Implanet S.A to -4.24
- Wartość Net debt/EBITDA organizacji Graham to -4.23